Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RAYOS vs IR Prednisone for Fatigue in SLE
NCT03098823Phase 4Completed
- Sponsor
- AMPEL BioSolutions
- Start
- Sep 2017
- Primary completion
- May 2019
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of prednisone in systemic lupus erythematosus (SLE) (2 arms), sponsored by AMPEL BioSolutions. Primary endpoint: Functional Assessment of Chronic Illness Therapy-Fatigue at 3 months. Started Sep 2017; status: completed.
02
Drugs
prednisone
03
Conditions
systemic lupus erythematosus (SLE)
Beyond the preview
Go deeper on NCT03098823.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03098823.